The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson’s Disease NATION Study Group
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background and Purpose Nonmotor symptoms (NMS) in Parkinson’s disease (PD) have multisystem origins with heterogeneous manifestations that develop throughout the course of PD. NMS are increasingly recognized as having a significant impact on the health-related quality of life (HrQoL). We aimed to determine the NMS presentation according to PD status, and the associations of NMS with other clinical variables and the HrQoL of Korean PD patients. Methods We surveyed patients in 37 movement-disorders clinics throughout Korea. In total, 323 PD patients were recruited for as¬sessment of disease severity and duration, NMS, HrQoL, and other clinical variables including demographics, cognition, sleep scale, fatigability, and symptoms. Results In total, 98.1% of enrolled PD subjects suffered from various kinds of NMS. The prevalence of NMS and scores in each NMS domain were significantly higher in the PD group, and the NMS worsened as the disease progressed. Among clinical variables, disease duration and depressive mood showed significant correlations with all NMS domains (p<0.001). NMS status impacted HrQoL in PD (rS=0.329, p<0.01), and the association patterns differed with the disease stage. Conclusions The results of our survey suggest that NMS in PD are not simply isolated symptoms of degenerative disease, but rather ex¬ert significant influences throughout the disease course. A novel clinical approach focused on NMS to develop tailored management strate¬gies is warranted to improve the HrQoL in PD patients.
Abstract
Background and Purpose Nonmotor symptoms (NMS) in Parkinson’s disease (PD) have multisystem origins with heterogeneous manifestations that develop throughout the course of PD. NMS are increasingly recognized as having a significant impact on the health-related quality of life (HrQoL). We aimed to determine the NMS presentation according to PD status, and the associations of NMS with other clinical variables and the HrQoL of Korean PD patients. Methods We surveyed patients in 37 movement-disorders clinics throughout Korea. In total, 323 PD patients were recruited for as¬sessment of disease severity and duration, NMS, HrQoL, and other clinical variables including demographics, cognition, sleep scale, fatigability, and symptoms. Results In total, 98.1% of enrolled PD subjects suffered from various kinds of NMS. The prevalence of NMS and scores in each NMS domain were significantly higher in the PD group, and the NMS worsened as the disease progressed. Among clinical variables, disease duration and depressive mood showed significant correlations with all NMS domains (p<0.001). NMS status impacted HrQoL in PD (rS=0.329, p<0.01), and the association patterns differed with the disease stage. Conclusions The results of our survey suggest that NMS in PD are not simply isolated symptoms of degenerative disease, but rather ex¬ert significant influences throughout the disease course. A novel clinical approach focused on NMS to develop tailored management strate¬gies is warranted to improve the HrQoL in PD patients.
참고문헌 (53)
- Fox SH, "The Movement Disorder Society evidence-based medicine review update:treatments for the motor symptoms of Parkinson’s disease", Mov Disord, 26(Suppl 3), pp.S2~S41 (2011)
- Seppi K, "The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease", Mov Disord, 26(Suppl 3), pp.S42~S80 (2011)
- Lee HM, "Many faces of Parkinson’s disease: non-motor symptoms of Parkinson’s disease", J Mov Disord, 8, pp.92~97 (2015)
- Chaudhuri KR, "Parkinson’s disease: the non-motor issues", Parkinsonism Relat Disord, 17, pp.717~723 (2011)
- Chaudhuri KR, "The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire", Mov Disord, 25, pp.704~709 (2010)
- Gallagher DA, "What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them?", Mov Disord, 25, pp.2493~2500 (2010)
- Lim SY, "The nonmotor symptoms of Parkinson’s disease--an overview", Mov Disord, 25(Suppl 1), pp.S123~S130 (2010)
- Chaudhuri KR, "Non-motor symptoms of Parkinson’s disease: diagnosis and management", Lancet Neurol, 5, pp.235~245 (2006)
- O’Sullivan SS, "Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study", Mov Disord, 23, pp.101~106 (2008)
- Postuma RB, "Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease", Mov Disord, 27, pp.617~626 (2012)
- Siderowf A, "Premotor Parkinson’s disease: clinical features, detection, and prospects for treatment", Ann Neurol, 64(Suppl 2), pp.S139~S147 (2008)
- Barone P, "The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease", Mov Disord, 24, pp.1641~1649 (2009)
- 권도영, "Translation and Validation of the Korean Version of the 39-Item Parkinson’s Disease Questionnaire", Journal of Clinical Neurology, 9(1), pp.26~31 (2013), 대한신경과학회[DOI]
- Soh SE, "Determinants of health-related quality of life in Parkinson’s disease: a systematic review", Parkinsonism Relat Disord, 17, pp.1~9 (2011)
- Hoehn MM, "Parkinsonism: onset, progression and mortality", Neurology, 17, pp.427~442 (1967)
- Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease, "The Unified Parkinson’s Disease Rating Scale (UPDRS):status and recommendations", Mov Disord, 18, pp.738~750 (2003)
- Jankovic J, "Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group", Neurology, 40, pp.1529~1534 (1990)
- 고성범, "Validation of the Korean-Version of the Nonmotor Symptoms Scale for Parkinson’s Disease", Journal of Clinical Neurology, 8(4), pp.276~283 (2012), 대한신경과학회[DOI]
- Kang Y, "A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients", J Korean Neurol Assoc, 15, pp.300~308 (1997)
- Lee JY, "Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment", J Geriatr Psychiatry Neurol, 21, pp.104~110 (2008)
- Kim TH, "Korean version of frontal assessment battery: psychometric properties and normative data", Dement Geriatr Cogn Disord, 29, pp.363~370 (2010)
- Choi SH, "The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients", J Korean Med Sci, 15, pp.609~615 (2000)
- Peto V, "The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease", Qual Life Res, 4, pp.241~248 (1995)
- Lim SY, "Overview of the extranigral aspects of Parkinson disease", Arch Neurol, 66, pp.167~172 (2009)
- Wolters ECh, "Non-motor extranigral signs and symptoms in Parkinson’s disease", Parkinsonism Relat Disord, 15(Suppl 3), pp.S6~S12 (2009)
- Shulman LM, "Non-recognition of depression and other non-motor symptoms in Parkinson’s disease", Parkinsonism Relat Disord, 8, pp.193~197 (2002)
- Chaudhuri KR, "The burden of non-motor symptoms in Parkinson’s disease using a self-completed non-motor questionnaire: a simple grading system", Parkinsonism Relat Disord, 21, pp.287~291 (2015)
- Braak H, "Staging of brain pathology related to sporadic Parkinson’s disease", Neurobiol Aging, 24, pp.197~211 (2003)
- Doder M, "Tremor in Parkinson’s disease and serotonergic dysfunction: an 11C-WAY 100635 PET study", Neurology, 60, pp.601~605 (2003)
- Remy P, "Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system", Brain, 128, pp.1314~1322 (2005)
- Shimada H, "Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET", Neurology, 73, pp.273~278 (2009)
- Martinez-Martin P, "The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease", Mov Disord, 26, pp.399~406 (2011)
- Chaudhuri KR, "Quantitation of non-motor symptoms in Parkinson’s disease", Eur J Neurol, 15(Suppl 2), pp.2~7 (2008)
- Goldman JG, "Premotor and nonmotor features of Parkinson’s disease", Curr Opin Neurol, 27, pp.434~441 (2014)
- Mollenhauer B, "Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort", Neurology, 81, pp.1226~1234 (2013)
- Alves G, "Changes in motor subtype and risk for incident dementia in Parkinson’s disease", Mov Disord, 21, pp.1123~1130 (2006)
- Schneider JS, "Relationship between motor symptoms, cognition, and demographic characteristics in treated mild", moderate Parkinson’s disease, 2015, pp.10, e0123231~
- Müller ML, "β-Amyloid and postural instability and gait difficulty in Parkinson’s disease at risk for dementia", Mov Disord, 28, pp.296~301 (2013)
- Rajput AH, "Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation", Neurology, 70, pp.1403~1410 (2008)
- Rajput AH, "Course in Parkinson disease subtypes: a 39-year clinicopathologic study", Neurology, 73, pp.206~212 (2009)
- Rosenberg-Katz K, "Gray matter atrophy distinguishes between Parkinson disease motor subtypes", Neurology, 80, pp.1476~1484 (2013)
- Khoo TK, "The spectrum of nonmotor symptoms in early Parkinson disease", Neurology, 80, pp.276~281 (2013)
- Herman T, "Cognitive function and other non-motor features in non-demented Parkinson’s disease motor subtypes", J Neural Transm (Vienna), 122, pp.1115~1124 (2015)
- Stacy M, "Nonmotor symptoms in Parkinson’s disease", Int J Neurosci, 121(Suppl 2), pp.9~17 (2011)
- Klepac N, "Association of rural life setting and poorer quality of life in Parkinson’s disease patients: a cross-sectional study in Croatia", Eur J Neurol, 14, pp.194~198 (2007)
- Lyons KE, "A comparison of Parkinson’s disease symptoms and self-reported functioning and well being", Parkinsonism Relat Disord, 3, pp.207~209 (1997)
- Zach M, "Quality of life in Polish patients with long-lasting Parkinson’s disease", Mov Disord, 19, pp.667~672 (2004)
- Chaudhuri KR, "Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment", Lancet Neurol, 8, pp.464~474 (2009)
- Todorova A, "Non-motor Parkinson’s: integral to motor Parkinson’s, yet often neglected", Pract Neurol, 14, pp.310~322 (2014)
- Kim HJ, "Nonmotor symptoms and subthalamic deep brain stimulation in Parkinson’s disease", J Mov Disord, 8, pp.83~91 (2015)
- Gallagher DA, "Impact of newer pharmacological treatments on quality of life in patients with Parkinson’s disease", CNS Drugs, 22, pp.563~586 (2008)
- Grosset D, "A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis", J Neurol Neurosurg Psychiatry, 78, pp.465~469 (2007)
- Witjas T, "Nonmotor fluctuations in Parkinson’s disease: frequent and disabling", Neurology, 59, pp.408~413 (2002)